Glycogen Storage Disease Type Ia (GSDIa) Disease Monitoring Program

RecruitingOBSERVATIONAL
Enrollment

140

Participants

Timeline

Start Date

November 4, 2024

Primary Completion Date

December 31, 2036

Study Completion Date

December 31, 2036

Conditions
Glycogen Storage Disease Type Ia
Interventions
OTHER

No Intervention

No investigational/study product will be administered in this DMP.

Trial Locations (19)

2700

RECRUITING

Rigshospitalet, Copenhagen

15706

RECRUITING

Hospital Clínico Universitario de Santiago, Santiago

16147

RECRUITING

Istituto G Gaslini Ospedale Pediatrico IRCCS, Genoa

19104

RECRUITING

Children's Hospital of Philadelphia, Philadelphia

20246

NOT_YET_RECRUITING

Universitätsklinikum Hamburg Eppendorf, Hamburg

27710

RECRUITING

Duke University Medical Center, Durham

44195

NOT_YET_RECRUITING

The Cleveland Clinic Foundation, Cleveland

48109

RECRUITING

University of Michigan, Ann Arbor

77030

RECRUITING

University of Texas Health Science Center at Houston, Houston

80045

NOT_YET_RECRUITING

Children's Hospital Colorado, Denver

80131

RECRUITING

University of Naples, Napoli

84108

NOT_YET_RECRUITING

Primary Children's Hospital, Salt Lake City

92868

RECRUITING

Children's Hospital of Orange County, Orange

06106

RECRUITING

University of Connecticut Health Center, Hartford

90035-903

NOT_YET_RECRUITING

Hospital de Clinicas de Porto Alegre (HCPA) - PPDS, Porto Alegre

H4A3J1

RECRUITING

McGill University Health Center, Montreal

534-0021

RECRUITING

Osaka City General Hospital, Osaka

470-1192

NOT_YET_RECRUITING

Fujita Health University Hospital, Toyoake

9700 RB

RECRUITING

Groningen University, Groningen

All Listed Sponsors
lead

Ultragenyx Pharmaceutical Inc

INDUSTRY